Delivery Order SPE2DB22D3501-SPE2DB25FXM61
- Not listed
- The Defense Logistics Agency awarded a $2,449.20 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 1, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units) valued at $3,391.20 with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract issued by the Medical Supply Chain, a division of the Defense Logistics Agency supporting the Department of Defense. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.00 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,177.50 on September 11, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,355.00 firm fixed-price delivery order for Narcan 4 mg nasal spray (2-pack units) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,355.00 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contract involves no set-aside designation, indicating it was competitively awarded through open...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on July 10, 2025, for the supply of Narcan 4 mg nasal spray (2 units) with a contract value of $1,183.00. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania, and scheduled for completion by July 11, 2025. The award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units) with a ceiling value of $1,667.87. This firm fixed price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a competitive, non-set-aside basis, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,841.52 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-pack units) with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,143.28 for Narcan 4 mg nasal spray (2-count units) on June 18, 2025, with completion targeted for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under AmerisourceBergen's broader pharmaceutical supply infrastructure...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXM61Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,668.69 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2 units) on September 23, 2025, with completion due by September 24, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and active through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and serves as a primary pharmaceutical distributor for federal medical procurement needs. AmerisourceBergen Drug Corp is a major healthcare solutions provider and pharmaceutical distributor that supplies a comprehensive range of medical products to military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's contract portfolio demonstrates capability across multiple therapeutic domains, including emergency medications such as Narcan (naloxone), as well as diabetes treatments, neurological medications, pain management pharmaceuticals, and specialty medical supplies. This delivery order for emergency opioid reversal medication supports the broader federal healthcare mission by ensuring critical life-saving pharmaceuticals are readily available to support military medical operations and readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/23/25 |